Characteristics | RT (n = 29) | Control (n = 30) | p value |
---|---|---|---|
Age (year) | 55.90 ± 8.05 | 56.57 ± 9.43 | 0.771 |
Gender (Male/Female) | 24/5 | 25/5 | 1.000 |
Operative time (min) | 229.17 ± 75.77 | 224.00 ± 78.12 | 0.797 |
Blood loss (ml) | 384.48 ± 317.38 | 372.67 ± 246.49 | 0.873 |
Operative procedure (Major/Minor) | 9/20 | 7/23 | 0.506 |
Operative method (Anatomical/Non-anatomical) | 14/15 | 12/18 | 0.522 |
Surgical margin (< 0.5 cm / ≥0.5 cm) | 19/10 | 16/14 | 0.341 |
Tumor size (cm) | 4.75 ± 2.15 | 4.50 ± 2.98 | 0.712 |
Number of tumor (single/multiple) | 27/2 | 28/2 | 1.000 |
Differentiation (Well-Moderate/Poorly) | 17/12 | 12/18 | 0.153 |
Tumor growth pattern (nodular / diffuse) | 29/0 | 30/0 | – |
MVI classification (M1/M2) | 19/10 | 21/9 | 0.713 |
Envelope invasion (Present/Absent) | 14/15 | 13/17 | 0.703 |
Fibrosis Scheuer S score (< 3 /≥3) | 14/15 | 12/18 | 0.522 |
HBV-Ag (Negative/Positive) | 5/24 | 3/27 | 0.417 |
Preoperative AFP level (Negative/≦400 ng/L / > 400 ng/) | 6/16/7 | 7/16/7 | 0.970 |
Preoperative ALT level (U/L) | 30.55 ± 18.79 | 32.67 ± 20.78 | 0.684 |
Preoperative TBIL level (umol/L) | 13.40 ± 5.32 | 15.49 ± 6.66 | 0.188 |
Preoperative ALB level (g/L) | 44.45 ± 3.55 | 42.72 ± 4.54 | 0.111 |
Preoperative PTa level (%) | 83.79 ± 11.08 | 83.81 ± 10.93 | 0.996 |